Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.

Felson DT, Anderson JJ, Meenan RF.

Arthritis Rheum. 1990 Oct;33(10):1449-61.

PMID:
1977391
[PubMed - indexed for MEDLINE]
2.

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

Felson DT, Anderson JJ, Meenan RF.

Arthritis Rheum. 1992 Oct;35(10):1117-25.

PMID:
1358078
[PubMed - indexed for MEDLINE]
3.

Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.

Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA.

J Rheumatol. 2002 Aug;29(8):1639-45.

PMID:
12180722
[PubMed - indexed for MEDLINE]
5.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.

Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Irby R, Wolfe F, et al.

Arthritis Rheum. 1990 Mar;33(3):330-8.

PMID:
2180405
[PubMed - indexed for MEDLINE]
8.

Methotrexate use in rheumatoid arthritis. A Clinician's perspective.

Alarcón GS.

Immunopharmacology. 2000 May;47(2-3):259-71. Review.

PMID:
10878293
[PubMed - indexed for MEDLINE]
9.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

PMID:
11961174
[PubMed - indexed for MEDLINE]
Free Article
10.

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.

O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.

Arthritis Rheum. 2002 May;46(5):1164-70.

PMID:
12115219
[PubMed - indexed for MEDLINE]
Free Article
11.

Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs.

Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C.

Rheumatology (Oxford). 2000 Sep;39(9):975-81.

PMID:
10986302
[PubMed - indexed for MEDLINE]
Free Article
12.

Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.

Weinblatt ME, Reda D, Henderson W, Giobbie-Hurder A, Williams D, Diani A, Docsa S.

J Rheumatol. 1999 Oct;26(10):2123-30.

PMID:
10529127
[PubMed - indexed for MEDLINE]
13.

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.

Choi HK, Seeger JD, Kuntz KM.

J Rheumatol. 2002 Jun;29(6):1156-65.

PMID:
12064828
[PubMed - indexed for MEDLINE]
14.

Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.

Schipper LG, Fransen J, Barrera P, Van Riel PL.

Rheumatology (Oxford). 2009 Jul;48(7):828-33. doi: 10.1093/rheumatology/kep090. Epub 2009 May 20.

PMID:
19458163
[PubMed - indexed for MEDLINE]
Free Article
15.

The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis.

Felson DT, Anderson JJ, Meenan RF.

Arthritis Rheum. 1994 Oct;37(10):1487-91.

PMID:
7945474
[PubMed - indexed for MEDLINE]
16.

Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients.

Elkayam O, Yaron M, Zhukovsky G, Segal R, Caspi D.

Rheumatol Int. 1997;17(2):49-53.

PMID:
9266620
[PubMed - indexed for MEDLINE]
17.

Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.

Ward JR.

Am J Med. 1988 Oct 14;85(4A):39-44. Review.

PMID:
3052055
[PubMed - indexed for MEDLINE]
18.

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.

Ferraccioli GF, Gremese E, Tomietto P, Favret G, Damato R, Di Poi E.

Rheumatology (Oxford). 2002 Aug;41(8):892-8.

PMID:
12154206
[PubMed - indexed for MEDLINE]
Free Article
19.

Multiple-outcome meta-analysis of clinical trials.

Berkey CS, Anderson JJ, Hoaglin DC.

Stat Med. 1996 Mar 15;15(5):537-57.

PMID:
8668877
[PubMed - indexed for MEDLINE]
20.

Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.

Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, Wakefield RJ, Reece RJ, Miles S, Adebajo A, Gough A, Helliwell P, Martin M, Huston G, Pease C, Veale DJ, Isaacs J, van der Heijde DM, Emery P.

Arthritis Rheum. 2000 Aug;43(8):1809-19.

PMID:
10943871
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk